Krankenhaus Nordwest

Therapy landscape in patients with metastatic HER2-positive breast cancer: Data from the PRAEGNANT real-world breast cancer registry (2019) Lux MP, Nabieva N, Hartkopf AD, Huober J, Volz B, Taran FA, Overkamp F, et al. Journal article Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients (2018) Nabieva N, Kellner S, Fehm T, Häberle L, De Waal J, Rezai M, Baier B, et al. Journal article Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study (2018) Nabieva N, Fehm T, Häberle L, De Waal J, Rezai M, Baier B, Baake G, et al. Journal article Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention (2018) Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, et al. Journal article Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers (2018) Taran FA, Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Overkamp F, et al. Journal article Update Breast Cancer 2018 (Part 4) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer (2018) Mueller V, Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, et al. Journal article Update Breast Cancer 2018 (Part 3) - Genomics, Individualized Medicine and Immune Therapies - in the Middle of a New Era: Prevention and Treatment Strategies for Early Breast Cancer (2018) Woeckel A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, et al. Journal article Efficacy and safety of Trifluridin/Tipiracil (FTD/TPI) (Lonsurf (R)) in patients with metastatic colorectal cancer (CRC) in clinical-routine use (2018) Cao J, Wiesweg M, Fuchs M, Stein A, Karthaus M, Lettmaier S, Kretzschmar A, et al. Conference contribution Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry (2018) Hartkopf AD, Huober J, Volz B, Nabieva N, Taran FA, Schwitulla J, Overkamp F, et al. Journal article Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry (2018) Mueller V, Nabieva N, Häberle L, Taran FA, Hartkopf AD, Volz B, Overkamp F, et al. Journal article